missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ripretinib, MedChemExpress
Description
Ripretinib (DCC-2618) targets and binds to both wild-type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. Ripretinib (DCC-2618) also inhibits multiple other kinase targets, such as FLT3 and KDR (or VEGFR-2). DCC-2618 exerts antineoplastic effect and induces apoptosis.
Specifications
Specifications
| Chemical Name or Material | Ripretinib |
| CAS | 1442472-39-0 |
| Color | Light Yellow |
| Purity Grade Notes | Research |
| Molecular Formula | C24H21BrFN5O2 |
| Quantity | 10 mg |
| Synonym | DCC-2618 |
| Solubility Information | DMSO : 25 mg/mL (48.99 mM; Need ultrasonic) |
| SMILES | O=C(NC1=CC(C2=CC3=C(C=C(NC)N=C3)N(CC)C2=O)=C(Br)C=C1F)NC4=CC=CC=C4 |
| Molecular Weight (g/mol) | 510.36 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?